Skip to main content

Kiely John

In the past year, 1 open-market sale filing worth $882.0K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$882.0K
1 filing
Net
−$882.0K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Kiely John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AMRX Amneal Pharmaceuticals, Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 26, 2024 (view filing)Nov 224 daysKiely JohnDirectorSSaleClass A Common Stock−17.1K$8.38−$142.9K−6.0%267.2K after
May 13, 2025 (view filing)May 121 dayKiely JohnDirectorSSaleClass A Common Stock−50.0K$7.59−$379.5K−16.3%257.4K after
Aug 28, 2025 (view filing)Aug 271 dayKiely JohnDirectorSSaleClass A Common Stock−32.0K$9.23−$295.4K−12.4%225.4K after
Aug 14, 2026 (view filing)4:29 PM ETAug 131 dayKiely JohnDirectorSSaleClass A Common Stock−50.0K$17.64−$882.0K−19.2%210.3K after